Histiocytic sarcoma – a malignant tumor

Behind this complicated name lies an aggressive form of cancer in dogs, also known as malignant histiocytosis, which mainly affects Bernese Mountain Dogs, Retrievers and Rottweilers and is one of the most common causes of death in these breeds as a hereditary disease. It primarily affects male dogs between the ages of two and eight. The disease is relatively rare in other dog breeds.

INHALT
Causes, development, and classification Symptoms Diagnosis Treatment Forecast Prophylaxis
Causes, development, and classification

Histiocytes are cells of the immune system that occur mainly in connective tissue, but also in all other organs, and act as "scavenger cells" that absorb and break down microorganisms, cell debris, and dead cells. A mutation causes the degenerated cells to multiply abnormally in one or more organs, with a pronounced tendency to metastasize (form secondary tumors). The secondary tumors spread rapidly and their invasive growth leads to severe organ damage and ultimately to the death of the animal.

The cause of this degeneration is still unknown. However, a genetic predisposition has been identified in Bernese Mountain Dogs.

In terms of how it appears, a distinction is made between whether the disease is localized (skin form) or spreads throughout the entire body (disseminated form). Another particularly aggressive form is hemophagocytic (= blood-eating) histiocytoma, which often affects the bone marrow. The tumor cells "eat" the red blood cells of the affected dog, causing anemia.

Symptoms

Since histiocytoma is a tumor of the hematopoietic system, it can affect almost any organ in the body, although the skin is usually not involved in the disseminated form. In most cases, the lungs, liver, spleen, lymph nodes, and bone marrow are affected. Depending on the location of the tumor, the appearance of the disease can therefore vary greatly and be less characteristic. Affected dogs usually show nonspecific symptoms such as weakness, fatigue, loss of appetite, fever, and weight loss. If the lungs are involved, breathing difficulties and coughing occur. In rare cases, ataxia, paralysis, or epileptic seizures may also occur. The disseminated form progresses rapidly and in most cases leads to death in less than six months.

The skin form manifests itself in the form of nodules and plaques on the skin, with the nasal and eye mucosa and, in males, the scrotum being particularly affected. The skin changes often occur in episodes, are difficult to define and tend to be ulcerative in nature. The disease worsens with each episode and metastasises particularly to the lymph nodes, spleen and bone marrow.

In the case of blood-eating histiocytoma, the absorption of red blood cells into the tumor cells leads to anemia, which causes pale mucous membranes and weakness. If you notice any such changes in your dog, please take it to a veterinarian immediately.

Diagnosis

The veterinarian will already have indications of a tumorous disease based on your preliminary report and a thorough clinical examination. Enlarged lymph nodes and swelling of the liver or spleen are usually present, but unfortunately, the disease is already advanced when symptoms appear.

This initial suspicion can be further confirmed with the help of an X-ray or ultrasound examination. However, X-rays and ultrasounds can only show an increase in size; the exact type of tumor can only be determined by taking a tissue sample. In a procedure known as fine needle aspiration, a thin, long needle is used to puncture the tumor and remove a cell sample, which can then be examined in the laboratory. The type of tumor can be determined more accurately based on the cell type and any changes. However, depending on the location of the tumor (e.g., lung), the examination can sometimes only be performed with high risks for the patient and therefore requires careful consideration. Diagnosis is more difficult for the veterinarian in the case of blood-eating histiocytoma, as although enlargement of the liver and spleen can be detected on X-ray or ultrasound, no actual tumors are visible.

Treatment

There is no cure for this type of cancer. Chemotherapy (drugs used to kill tumor cells) or radiation therapy are used to treat the disease, but these treatments can only improve the dog's quality of life and delay the progression of the disease. Surgical measures are also rarely practical or promising due to the location of the tumors. In cases of severe, therapy-resistant symptoms, such as severe shortness of breath due to tumor masses in the lungs, the animal should be euthanized in view of the hopeless prognosis.

Forecast

The prognosis for this aggressive form of cancer is generally poor. Despite a wide range of treatment options, there is no cure. Depending on the type of tumor, the type of treatment, and the response to treatment, the life expectancy of affected animals ranges from a few weeks to a few months after diagnosis.

Prophylaxis

Since it is still unknown why the cells degenerate, prevention in the true sense of the word is not possible. Due to the genetic predisposition of Bernese Mountain Dogs, a genomic test has been developed in collaboration with a German university that provides breeders with information about the longevity and risk of their breeding dogs developing HS. These results enable responsible breeders to carry out targeted mating to reduce the incidence of the disease.